Buccal mucosa as a route for systemic drug delivery: A review

International Journal of Drug Development and Research

Volumn 4, Issue 2, 2012, Pages 99-116

  Patel, Dhaval A ^a   Patel, M R ^a   Patel, K R ^a   Patel, N M ^a  

^a Shri B M Shah College of Pharmacy Modasa   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA INTERFERON; BUSERELIN; DEOXYCHOLATE SODIUM; DEXTRAN; EDETIC ACID; FLUORESCEIN ISOTHIOCYANATE; GLYCOCHOLATE SODIUM; INSULIN; LUTEINIZING HORMONE; OCTREOTIDE; POLYACRYLIC ACID; POLYMACON; POLYMER; POLYMETHACRYLIC ACID; SALICYLIC ACID;

ARTICLE; BASEMENT MEMBRANE; BUCCAL DRUG ADMINISTRATION; CELL ADHESION; CELL MEMBRANE; CELL SURFACE; CHEEK MUCOSA; CONCENTRATION (PARAMETERS); CROSS LINKING; CYTOPLASM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; HUMAN; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; INTERCELLULAR SPACE; KERATINIZATION; LIPOPHILICITY; MOLECULAR WEIGHT; MUCOADHESION; NONHUMAN; PARTITION COEFFICIENT; PH; PROTON TRANSPORT; SALIVA; TURNOVER TIME;

EID: 84870183779     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (109)

1. Aungst, B.J., Rogers, N.J., and Shefter, E., Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter, The J. Pharmacol. Exp. Ther., 244:23-27, 1988.
2. Aungst, B.J. and Rogers, N.J., Site dependence of absorption-promoting actions of Laureth-9, Na salicylate, Na2EDTA, and Aprotinin on rectal, nasal, and buccal insulin delivery, Pharm. Res., 5:305-308, 1988.
3. Lee, W.E., Permeation enhancers for the nasal delivery of protein and peptide therapeutics, Bio Pharm, 3:22-25, 1990.
4. Tengamnuay, P. and Mitra, A.K., Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. I. Effects of ionic strength. adjuvant composition, and lipid structure on the nasal absorption of [D-Arg2]Kyotorphin, Pharm. Res., 7:127-133, 1990.
5. Shao, Z. and Mitra, A.K., Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport, Pharm. Res., 9:1992, 1992.
6. Shao, Z. and Mitra, A.K., Bile salt fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs, Pharm. Res., 11:243-250, 1994.
7. Soyani, A.P. and Chien, Y.W., Systemic delivery of peptides and proteins across absorptive mucosae, Crit. Rev. Therap. Drug Carrier Systems, 13:85-184, 1996.
8. Adjei, A., Sundberg, D., Miller, J., and Chun, A., Bioavailability of leuprolide acetate following nasal inhalation delivery to rats and healthy humans, Pharm. Res., 9:244-249, 1992.
9. Shimamoto, T., Pharmaceutical aspects. Nasal and depot formulations of leuprolide, J. Androl., 8:S14-S16, 1987.
10. Dal Negra, R., Turco, P., Pomari, C., and Trevisan, F., Calcitonin nasal spray in patienmts with chronic asthma: a double-blind crossover study vs placebo, Int. J. Clin. Pharmacol. Ther. Toxicol., 29:144-146, 1991.
11. Plosker, G.L. and McTavish, D., Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis, Drugs Aging, 8:378-400, 1996.
12. Reginster, J.Y. and Lecart, M.P., Efficacy and safety of drugs for Paget's disease of bone, Bone, 17:485S-488S, 1995.
13. Rathbone, M.J. and Hadgraft, J., Absorption of drugs from the human oral cavity, Int. J. Pharm., 74:9-24, 1991.
14. de Vries, M.E., Bodde, H.E., Verhoef, J.C., and Junginger, H.E., Developments in buccal drug delivery, Crit. Rev. Ther. Drug Carr. Sys., 8:271-303, 1991.
15. Squier, C.A., The permeability of oral mucosa, Crit. Rev. Oral Biol. Med., 2:13-32, 1991.
16. Bodde, H.E., De Vries, M.E., and Junginger, H.E., Mucoadhesive polymers for the buccal delivery of peptides, structure-adhesiveness relationships, J. Control. Rel., 13:225-231, 1990.
17. Gandhi, R.E. and Robinson, J.R., Bioadhesion in drug delivery, Ind. J. Pharm. Sci., 50:145-152, 1988.
18. Harris, D. and Robinson, J.R., Drug delivery via the mucous membranes of the oral cavity, J. Pharm. Sci., 81:1-10, 1992.Reproduced with permission of the American Pharmaceutical Association.
19. Wertz, P.W. and Squier, C.A., Cellular and molecular basis of barrier function in oral epithelium, Crit. Rev. Ther. Drug Carr. Sys., 8:237-269, 1991.
20. Squier, C.A., Cox, P., and Wertz, P.W., Lipid content and water permeability of skin and oral mucosa, The J. Invest. Dermat., 96:123-126, 1991.
21. Squier, C.A. and Wertz, P.W. Structure and function of the oral mucosa and implications for drug delivery, in eds. M.J. Rathbone, Oral Mucosal Drug Delivery, Marcel Dekker, Inc., New York, New York, 1-26, 1996.
22. Galey, W.R., Lonsdale, H.K., and Nacht, S., The in vitro permeability of skin and buccal mucosa toselected drugs and tritiated water, J. Invest. Dermat., 67:713-717, 1976.
23. Gandhi, R.B. and Robinson, J.R., Oral cavity as a site for bioadhesive drug delivery, Adv. Drug Del. Rev., 13:43-74, 1994.
24. Squier, C.A. and Hall, B.K., The permeability of mammalian non-keratinized oral epithelia to horseraddish peroxidase applied in vivo and in vitro, Arch. Oral Biol., 29:45-50, 1984.
25. Hill, M.W. and Squier, C.A., The permeability of oral palatal mucosa maintained in organ culture, J. Anat., 128:169-178, 1979.
26. Tabak, L.A., Levine, M.J., Mandel, I.D., and Ellison, S.A., Role of salivary mucins in the protection of the oral cavity, J. Oral Pathol., 11:1-17, 1982.
27. Peppas, N.A. and Buri, P.A., Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues, J. Control. Rel., 2:257-275, 1985.
28. Rathbone, M., Drummond, B., and Tucker, I., Oral cavity as a site for systemic drug delivery, Adv. Drug Del. Rev., 13:1-22, 1994.
29. Edgar, W.M., Saliva: its secretion, composition and functions, Br. Dent. J., 172:305-312, 1992.
30. Ishida, M., Nambu, N., and Nagai, T., Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and carbopol, Chem. Pharm. Bull., 30:980-984, 1982.
31. Collins, A.E.M., Deasy, P.B., Mac Carthy, D.J., and Shanley, D.B., Evaluation of a controlled release compact containing tetracycline hydrochloride bonded to tooth for the treatment of periodontal disease, Int. J. Pharm., 51:103-114, 1989.
32. Elkayam, R., Friedman, M., Stabholz, A., Soskolne, A.w., Sela, M.N., and Golub, L., Sustained release device containing minocycline for local treatment of periodontal disease, J. Control. Rel., 7:231-236, 1988.
33. Samaranayake, L. and Ferguson, M., Delivery of antifungal agents to the oral cavity, Adv. Drug Del. Rev., 13:161-179, 1994.
34. Nagai, T., Adhesive topical drug delivery system, J. Control. Rel., 2:121-134, 1985.
35. Nagai, T. and Machida, Y., Mucosal adhesive dosage forms, Pharm. Int., 196-200, 1985.
36. Aungst, B.J. and Rogers, N.J., Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery, Int. J. Pharm., 53:227-235, 1989.
37. Siegel, I.A. and Gordon, H.P., Surfactant-induced increase of permeability of rat oral mucosa to nonelectolytes in vivo, Arch. Oral Biol., 30:43-47, 1985.
38. Shojaei, A.H. and Li, X., In vitro permeation of acyclovir through porcine buccal mucosa, Proceedings of International Symposium on Controlled Release of Bioactive Materials, 23:507-508, 1996.
39. Shojaei, A.H. and Li, X., Determination of transport route of acyclovir across buccal mucosa, Proceed. Int. Symp. Control. Rel. Bioact. Mater., 24:427-428, 1997.
40. Manganaro, A.M. and Wertz, P.W., The effects of permeabilizers on the in vitro penetration of propranolol through porcine buccal epithelium, Mil. Med., 161:669-672, 1996.
41. Gandhi, R. and Robinson, J., Mechanisms of penetration enhancement for transbuccal delivery of salicylic acid, Int. J. Pharm., 85:129-140, 1992.
42. Hoogstraate, A.J., Verhoef, J.C., Tuk, B., Pijpers, A., van leengoed, L.A.M.G., Vheijden, J.H.M., Junjinger, H.E., and Bodde, H.E., Buccal delivery of fluorescein isothiocyanate-dextran 4400 and the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs, J. Control. Rel., 41:77-84, 1996.
43. Wolany, G.J.M., Munzer, J., Rummelt, A., and Merkle, H.P., Buccal absorption of Sandostatin (octreotide) in conscious beagle dogs, Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 17:224-225, 1990.
44. Nakane, S., Kakumoto, M., Yulimatsu, K., and Chien, Y.W., Oramucosal delivery of LHRH: Pharmacokinetic studies of controlled and enhanced transmucosal permeation, Pharm. Dev. Tech., 1:251-259, 1996.
45. Steward, A., Bayley, D.L., and Howes, C., The effect of enhancers on the buccal absorption of hybrid (BDBB) alpha-interferom, Int. J. Pharm., 104:145-149, 1994.
46. Senel, S., Hoogstraate, A.J., Spies, F., Verhoef, J.C., Bos-van Geest, A., Junginger, H.E., and Bodde, H.E., Enhancement of in vitro permeability of porcine buccal mucosa by bile salts: kinetic and histological studies, J. Control. Rel., 32:45-56, 1994.
47. Hoogstraate, A.J., Senel, S., Cullander, C., Verhoef, J., Junginger, H.E., and Bodde, H.E., Effects of bile salts on transport rates and routes of FTIC-labelled compounds across porcine buccal epithelium in vitro, J. Control. Rel., 40:211-221, 1996.
48. Oh, C.K. and Ritschel, W.A., Biopharmaceutic aspects of buccal absorption of insulin, Meth. Find Exp. Clin. Pharmacol., 12:205-212, 1990.
49. Zhang, J., Niu, S., Ebert, C., and Stanley, T.H., An in vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers: apparent evidence of effective enhancement without tissue damage, Int. J. Pharm., 101:15-22, 1994.
50. Aungst, B.J., Site-dependence and structure-effect relationships for alkylglycosides as transmucosal absorption promoters for insulin, Int. J. Pharm., 105:219-225, 1994.
51. Kurosaki, Y., Hisaichi, S., Hong, L., Nakayama, T., and Kimura, T., Enhanced permeability of keratinized oral-mucosa to salicylic acid with 1-dodecylacycloheptan-2-one (Azone). In vitro studies in hamster cheek pouch, Int. J. Pharm., 49:47-55, 1989.
52. Kurosaki, Y., Hisaichi, S., Nakayama, T., and Kimura, T., Enhancing effect of 1-dodecylazacycloheptan-2-one (Azone) on the absorption of salicyclic acid from keratinized oral mucosa and the duration of enhancement in vivo, Int. J. Pharm., 51:47-54, 1989.
53. Siegel, I.A. and Gordon, H.P., Effects of surfactants on the permeability of canine oral mucosa in vitro, Tox. Lett., 26:153-157, 1985.
54. Kurosaki, Y., Hisaichi, S., Hamada, C., Nakayama, T., and Kimura, T., Effects of surfactants on the absorption of salicylic acid from hamster cheek pouch as a model of keratinized oral mucosa, Int. J. Pharm., 47:13-19, 1988.
55. Siegel, I.A., Izutsu, K.T., and Watson, E., Mechanisms of non-electrolyte penetration across dog and rabbit oral mucosa in vitro, Arch. Oral Biol., 26:357-361, 1981.
56. Coutel-Egros, A., Maitani, Y., Veillard, M., Machida, Y., and Nagai, T., Combined effects of pH, cosolvent and penetration enhancers on the in vitro buccal absorption of propranolol through excised hamster cheek pouch, Int. J. Pharm., 84:117-128, 1992.
57. Ishida, M., Machida, Y., Nambu, N., and Nagai, T., New mucosal dosage form of insulin, Chem. Pharm. Bull., 29:810-816, 1981.
58. Dowty, M.E., Knuth, K.E., Irons, B.K., and Robinson, J.R., Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro, Pharm. Res., 9:1113-1122, 1992.
59. Tavakoli-Saberi, M.R. and Audus, K.L., Cultured buccal epithelium: an in vitro model derived from the hamster pouch for studying drug transport and metabolism, Pharm. Res., 6:160-162, 1989.
60. Tavakoli-Saberi, M.R., Williams, A., and Audus, K.L., Aminopeptidase activity in human buccal epithelium and primary cultures of hamster buccal epithelium, Pharm. Res., 6:S-197, 1989.
61. Leipold, H.R. and Quadros, E., Nicotine permeation through buccal cultures, Proceed. Int. Symp. Control. Rel. Bioact. Mater., 20:242-243, 1993.
62. Beckett, A.H. and Triggs, E.J., Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes, J. Pharm. Pharmacol., 19:31S-41S, 1967.
63. Schurmann, W. and Turner, P., A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the beta-blocking drugs atenolol and propranolol, J. Pharm. Pharmacol., 30:137-147, 1978.
64. Tucker, I.G., A method to study the kinetics of oral mucosal drug absorption from solutions, J. Pharm. Pharmacol., 40:679-683, 1988.
65. Barsuhn, C.L., Olanoff, L.S., Gleason, D.D., Adkins, E.L., and Ho, N.F.H., Human buccal absorption of flubriprofen, Clin. Pharmacol. Ther., 44:225-231, 1988.
66. Gonzalez-Younes, I., Wagner, J.G., and Gaines, D.A., Absorption of flubriprofen through human buccal mucosa, J. Pharm. Sci., 80:820-823, 1991.
67. Benes, L., et al. Plasma melatonin (M) and sulfatoxymelatonin (aMT6s) kinetics after transmucosal administration to humans, in eds. Y. Touitou, J. Arendt, andP. Pevet, Melatonin and the pineal gland-From basic science to clinical application, Elsevier Science Publishers B.V., New York, 347-350, 1993.
68. McQuinn, R.L., Kvam, D.C., Maser, M.J., Miller, A.L., and Oliver, A., Sustained oral mucosal delivery in human volunteers of buprenorphine from thin non-eroding mucoadhesive polymeric disks, J. Control. Rel., 34:243-250, 1995.
69. Benes, L., et al., Transmucosal, oral controlledrelease, transdermal drug administration in human subjects: A crossover study with melatonin, Journal of Pharm. Sci., 86:1115-1119, 1997.
70. Veillard, M.M., Longer, M.A., Martens, T.W., and Robinson, J.R., Preliminary studies of oral mucosal delivery of peptide drugs, J. Control. Rel., 6:123-131, 1987.
71. Yamahara, H. and Lee, V.H., Drug Metabolism in the Oral Cavity, Adv. Drug Del. Rev., 12:25-39, 1993.
72. Tanaka, M., Yanagibashi, N., Fukuda, H., and Nagai, T., Absorption of salicylic through the oral mucous membrane of hamster cheek pouch, Chem. Pharm. Bull., 28:1056-1061, 1980.
73. Siegel, I.A. and Gordon, H.P., Surfactant-induced alterations of permeability of rabbit oral mucosa in vitro, Exp. Mol. Path., 44:132-137, 1986.
74. Dowty, M.E., Knuth, K.E., and Robinson, J.R., Enzyme characterization studies on the ratelimiting barrier in rabbit buccal mucosa, Int. J. Pharm., 88:293-302, 1992.
75. Mehta, M., Kemppainen, B.W., and Staffford, R.G., In vitro penetration of tritium-labelled water (THO) and [3H]PbTx-3 (a red tide toxin) through monkey buccal mucosa and skin, Tox. Lett., 55:185-194, 1991.
76. Lesch, C.A., Squier, C.A., Cruchley, A., Williams, D.M., and Speight, P., The permeability of human oral mucosa and skin to water, J. Dent. Res., 68:1345-1349, 1989.
77. Quadros, E., Cassidy, J., Gniecko, K., and LeRoy, S., Buccal and colonic absorption of CGS 16617, a novel ACE inhibitor, J. Control. Rel., 19:77-86, 1991.
78. Squier, C.A. and Hall, B.K., The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier, The J. Invest. Dermat., 84:1985.
79. Hoogstraate, A.J., Cullander, C., Nagelkerke, J.F., Verhoel, J., Junginger, H.E., and Bodde, H.E., Diffusion rates and transport pathways of FITClabelled model compounds through buccal epithelium, Proceed. Int. Symp. Control. Rel. Bioact. Mater., 20:234-235, 1993.
80. Hoogstraate, A.J., Bodde, H.E., Cullander, C., and Junginger, H.E., Diffusion rates and transport pathways of FITC-labelled model compounds through buccal epithelium, Pharm. Res., 9:S-188, 1992.
81. Collins, P., Laffoon, J., and Squier, C.A., Comparative study of porcine oral epithelium, J. Dent. Res., 60:543, 1981.
82. Ch'ng, H.S., Park, H., Kelly, P., and Robinson, J.R., Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers, J. Pharm. Sci., 74:399-405, 1985.
83. Leung, S.S. and Robinson, J.R., Polymer structure features contributing to mucoadhesion: II., J. Control. Rel., 12:187-194, 1990.
84. Sanzgiri, Y.D., Topp, E.M., Benedetti, L., and Stella, V.J., Evaluation of mucoadhesive properties of hyaluronic caid benzyl esters, Int. J. Pharm., 107:91-97, 1994.
85. Lehr, C.M., Bouwstra, J.A., Schact, E.H., and Junginger, H.E., In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, Int. J. Pharm., 78:43-48, 1992.
86. Park, K. and Robinson, J.R., Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion, Int. J. Pharm., 19:107-127, 1984.
87. Nagai, T. and Machida, Y., Buccal delivery systems using hydrogels, Adv. Drug Del. Rev., 11:179-191, 1993.
88. Satoh, K., Takayama, K., Machida, Y., Suzuki, Y., Nakagaki, M., and Nagai, T., Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and carboxyvinyl polymer., Chem. Pharm. Bull., 37:1366-1368, 1989.
89. Gupta, A., Garg, S., and Khar, R.K., Interpolymer complexation and its effect on bioadhesion strength and dissolution characteristics of buccal drug delivery systems, Drug Dev. Ind. Pharm., 20:315-325, 1994.
90. Anlar, S., Capan, Y., Guven, O., Gogus, A., Dlakara, T., and Hincal, A.A., Formulation and in-vitro-in vivo evaluation of buccoadhesive morphine sulfate tablets, Pharm. Res., 11:231-236, 1994.
91. Anders, R. and Merkle, H., Evaluation of laminated muco-adhesive patches for buccal drug delivery, Int. J. Pharm., 49:231-240, 1989.
92. Guo, J.-H., Investigating the surface properties and bioadhesion of buccal patches, J. Pharm. Pharmacol., 46:647-650, 1994.
93. Watanabe, K., Yakou, S., Takayama, K., Machida, Y., and Nagai, T., Drug release behaviors from hydrogel prepared with water soluble dietary fibers, J. Pharm. Sci. Techn. Jpn., 51:29-35, 1991.
94. Anders, R., Merkle, H.P., Schurr, W., and Ziegler, R., Buccal absorption of protirelin: an effective way to stimulate thyrotropin and prolactin, J. Pharm. Sci., 72:1481-1483, 1983.
95. Park, H. and Robinson, J.R., Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels, Pharm. Res., 4:457-464, 1987.
96. Garcia-Gonzalez, N., Kellaway, I., Blanco-Fuente, H., Anguiano-Igea, S., Delgado-Charro, B., Otero-Espinar, F., and Blanco-Mendez, J., Design and evaluation of buccoadhesive metoclopramide hydrogels composed of poly(acrylic acid) crosslinked with sucrose, Int. J. Pharm., 100:65-70, 1993.
97. Leung, S. and Robinson, J.R., The contribution of anionic polymer structural features to mucoadhesion, J. Control. Rel., 5:223-231, 1988.
98. Cassidy, J.P., Landzert, N.M., and Quadros, E., Controlled buccal delivery of buprenorphine, J. Control. Rel., 25:21-29, 1993.
99. DeGrande, G., Benes, L., Horriere, F., Karsenty, F., LaCoste, C., McQuinn, R., Guo, J., and Scherrer, R. Specialized oral mucosal drug delivery systems: Patches, in eds. M.J. Rathbone, Oral Mucosal Drug Delivery, Marcel Dekker, Inc., New York, 285-318, 1996.
100. Nguyen-Xuan, T., Towart, R., Terras, A., Jacques, Y., Buri, P., and Gurny, R., Mucoadhesive semisolid formulations for intraoral use containing sucralfate, Eur. J. Pharm. Biopharm., 43:133-137, 1996.
101. Nair, M. and Chien, Y.W., Development of anticandidal delivery systems: (II) Mucoadhesive devices for prolonged drug delivery in the oral cavity, Drug Dev. Ind. Pharm., 22:243-253, 1996.
102. Taylan, B., Yilmaz, C., Guven, O., Kes, S., and Hincal, A.A., Design and evaluation of sustainedrelease and buccal adhesive propranolol hydrochloride tablets, J. Control. Rel., 38:11-20, 1996.
103. Yukimatsu, K., Nozaki, Y., Makumoto, M., and Ohta, M., Development of a trans-mucosal controlled-release device for systemic of antianginal drugs pharmacokinetics and pharmacodynamics, Drug Dev. Ind. Pharm., 20:503-534, 1994.
104. Nozaki, Y., Ohta, M., and Chien, Y.W., Transmucosal controlled systemic delivery of isosorbide dinitrate: in vivo/in vitro correlation, J. Control. Rel., 43:105-114, 1997.
105. Shojaei, A.H. and Li, X., Novel copolymers of acrylic acid and poly ethylene glycol monomethylether monomethacrylate for buccal mucoadhesion: Preparation and surface characterization, Pharm. Res., 12 (S1):S210, 1995.
106. Li, X. and Shojaei, A.H., Novel copolymers of acrylic acid and poly ethylene glycol monomethylether monomethacrylate for buccoadhesion: In vitro assessment of buccoadhesion and analysis of surface free energy, Proceed. Int. Symp. Control. Rel. Bioact. Mater., 23:165-166, 1996.
107. Shojaei, A.H. and Li, X., Mechanisms of buccal mucoadhesion of novel copolymers of acrylic acidand polyethylene glycol monomethylether monomethacrylate, J. Control. Rel., 47:151-161, 1997.
108. Choi, H.K., Kim, O.J., Jung, C.K., Cho, Y.J., and Cho, C.S., Interpolymer complex prepared by template polymerization for transmucosal drug delivery, Proceed. Int. Symp. Control. Rel. Bioact. Mater., 24:415-416, 1997.
109. Voorspoels, J., Comhaire, F., De Sy, W., and Remon, J.P., Buccal absorption of progesterone in the dog, Proceed. Int. Symp. Control. Rel. Bioact. Mater., 24:185-186, 1997.